Rebecca Lee Haffajee — Publications

Legal Review of State Emergency Medical Services Policies and Protocols for Naloxone Administration

2022
Common Themes in Early State Policy Responses to Substance Use Disorder Treatment During COVID-19

2021
Opioid Litigation: What's New, and What Does It Mean for Future Litigation?

2021
Pregnant Women with Substance Use Disorders: The Harm Associated with Punitive Approaches

2021
Use of Buprenorphine for Those with Employer-Sponsored Insurance During the Initial Phase of the COVID-19 Pandemic

2021
Abuses of FDA Regulatory Procedures: The Case of Suboxone

2020
Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries

2020
The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review

2020
The Complex Cancer Care Coverage Environment: What Is the Role of Legislation? A Case Study from Massachusetts

2020
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19

2020
Legal Requirements and Recommendations to Prescribe Naloxone

2020
A Mixed-Method Comparison of Physician-Reported Beliefs About and Barriers to Treatment with Medications for Opioid Use Disorder

2020
Opioid Prescribing History Prior to Heroin Overdose Among Commercially Insured Adults

2020
Prevalence and Predictors of Driving After Prescription Opioid Use in an Adult ED Sample

2020
The Public Health Value of Opioid Litigation

2020
Thinking Globally, Acting Locally: The U.S. Response to Covid-19

2020
Association of State Opioid Duration Limits With Postoperative Opioid Prescribing

2019
Generic Drug Policy and Suboxone to Treat Opioid Use Disorder

2019
Settling the Score: Maximizing the Public Health Impact of Opioid Litigation

2019
Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages

2018

U.S. research divisions

International research divisions

Rebecca Lee Haffajee — Publications

Legal Review of State Emergency Medical Services Policies and Protocols for Naloxone Administration

Common Themes in Early State Policy Responses to Substance Use Disorder Treatment During COVID-19

Opioid Litigation: What's New, and What Does It Mean for Future Litigation?

Pregnant Women with Substance Use Disorders: The Harm Associated with Punitive Approaches

Use of Buprenorphine for Those with Employer-Sponsored Insurance During the Initial Phase of the COVID-19 Pandemic

Abuses of FDA Regulatory Procedures: The Case of Suboxone

Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries

The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review

The Complex Cancer Care Coverage Environment: What Is the Role of Legislation? A Case Study from Massachusetts

An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19

Legal Requirements and Recommendations to Prescribe Naloxone

A Mixed-Method Comparison of Physician-Reported Beliefs About and Barriers to Treatment with Medications for Opioid Use Disorder

Opioid Prescribing History Prior to Heroin Overdose Among Commercially Insured Adults

Prevalence and Predictors of Driving After Prescription Opioid Use in an Adult ED Sample

The Public Health Value of Opioid Litigation

Thinking Globally, Acting Locally: The U.S. Response to Covid-19

Association of State Opioid Duration Limits With Postoperative Opioid Prescribing

Generic Drug Policy and Suboxone to Treat Opioid Use Disorder

Settling the Score: Maximizing the Public Health Impact of Opioid Litigation

Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages